Geron reported $54.46M in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Amgen USD 5.69B 6B Sep/2026
Bio Techne USD 243.9M 17.7M Sep/2026
Cassava Sciences USD 9.39M 1.78M Jun/2026
Cytokinetics USD 214.64M 6.85M Sep/2026
Exelixis USD 390.27M 10M Sep/2026
Genmab DKK 748M 77M Jun/2026
Geron USD 54.46M 15.67M Sep/2026
Gilead Sciences USD 13.04B 9.09B Sep/2026
Incyte USD 5.64B 4.67B Sep/2026
MacroGenics USD 25.15M 17.72M Sep/2026
Novartis USD 9.88B 325M Sep/2026
Novavax USD 126.2M 23.62M Dec/2025